Anthony Peterson, MD
Dermatology · Naperville, ILNPI 1144424649
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $703 of the $865 with a category attached, or 81.3%. It is spread thinly across 9 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $493, 9.7 times the $51 reported in 2022. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.
Across 34 payments — averaging $25.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$191
- Sanofi$174
- Pfizer$147
- Novartis$129
- AbbVie$83
- Johnson & Johnson$77
- plus $65 from 3 others
What the payments were for
- Food & beverage$70381%
- Education$16219%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 5 | $191 |
| Sanofi | 4 | $174 |
| Pfizer | 9 | $147 |
| Novartis | 7 | $129 |
| AbbVie | 4 | $83 |
| Johnson & Johnson | 2 | $77 |
| Dermavant Sciences, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Amgen | 1 | $16 |
How this compares
$865 in reported general payments places this provider in the 30th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 11 | $76,134 |
| Dupixent PenDupilumab | 17 | $62,113 |
| Fluorouracil | 73 | $5,271 |
| Clobetasol Propionate | 106 | $4,411 |
| Azelaic Acid | 50 | $4,263 |
| Metronidazole | 64 | $2,587 |
| Triamcinolone Acetonide | 241 | $1,823 |
| Doxycycline Hyclate | 60 | $1,504 |
| Ketoconazole | 100 | $1,451 |
| Dapsone | 13 | $1,310 |
| Econazole Nitrate | 21 | $1,210 |
| Fluocinonide | 32 | $984 |
| Naltrexone Hcl | 18 | $920 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 20 | $879 |
| Hydrocortisone | 195 | $799 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Naperville
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.